326 related articles for article (PubMed ID: 23747076)
1. Psychometric performance of the incontinence quality-of-life questionnaire among patients with overactive bladder and urinary incontinence.
Patrick DL; Khalaf KM; Dmochowski R; Kowalski JW; Globe DR
Clin Ther; 2013 Jun; 35(6):836-45. PubMed ID: 23747076
[TBL] [Abstract][Full Text] [Related]
2. OnabotulinumtoxinA improves health-related quality of life in patients with urinary incontinence due to idiopathic overactive bladder: a 36-week, double-blind, placebo-controlled, randomized, dose-ranging trial.
Fowler CJ; Auerbach S; Ginsberg D; Hale D; Radziszewski P; Rechberger T; Patel VD; Zhou J; Thompson C; Kowalski JW
Eur Urol; 2012 Jul; 62(1):148-57. PubMed ID: 22464310
[TBL] [Abstract][Full Text] [Related]
3. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
[TBL] [Abstract][Full Text] [Related]
4. Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ).
Matza LS; Thompson CL; Krasnow J; Brewster-Jordan J; Zyczynski T; Coyne KS
Neurourol Urodyn; 2005; 24(3):215-25. PubMed ID: 15747340
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire.
Haab F; Richard F; Amarenco G; Coloby P; Arnould B; Benmedjahed K; Guillemin I; Grise P
Urology; 2008 Apr; 71(4):646-56. PubMed ID: 18313122
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire.
Piault E; Evans CJ; Espindle D; Kopp Z; Brubaker L; Abrams P
Neurourol Urodyn; 2008; 27(3):179-90. PubMed ID: 17565727
[TBL] [Abstract][Full Text] [Related]
7. IQOL: translation & reliability for use with urinary incontinence patients in Thailand.
Chaisaeng S; Santingamkun A; Opanuraks J; Ratchanon S; Bunyaratavej C
J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S33-9. PubMed ID: 17722303
[TBL] [Abstract][Full Text] [Related]
8. Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity.
Sussman D; Patel V; Del Popolo G; Lam W; Globe D; Pommerville P
Neurourol Urodyn; 2013 Mar; 32(3):242-9. PubMed ID: 22965657
[TBL] [Abstract][Full Text] [Related]
9. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug.
Kubota Y; Kojima Y; Shibata Y; Imura M; Kohri K; Sasaki S
Neurourol Urodyn; 2011 Sep; 30(7):1309-14. PubMed ID: 21560155
[TBL] [Abstract][Full Text] [Related]
10. Psychometric properties of the incontinence utility index among patients with idiopathic overactive bladder: data from two multicenter, double-blind, randomized, Phase 3, placebo-controlled clinical trials.
Castejón N; Khalaf K; Ni Q; Cuervo J; Patrick DL
Health Qual Life Outcomes; 2015 Aug; 13():116. PubMed ID: 26231052
[TBL] [Abstract][Full Text] [Related]
11. Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q).
Margolis MK; Fox KM; Cerulli A; Ariely R; Kahler KH; Coyne KS
Neurourol Urodyn; 2009; 28(5):416-22. PubMed ID: 19030182
[TBL] [Abstract][Full Text] [Related]
12. Impact of stress urinary incontinence and overactive bladder on quality of life in Thai women attending the urogynecology clinic.
Wattanayingcharoenchai R; Manonai J; Vannatim N; Saritapirak S; Imsomboon C; Chittacharoen A
J Med Assoc Thai; 2007 Jan; 90(1):26-31. PubMed ID: 17621729
[TBL] [Abstract][Full Text] [Related]
13. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial.
Nitti VW; Dmochowski R; Herschorn S; Sand P; Thompson C; Nardo C; Yan X; Haag-Molkenteller C;
J Urol; 2013 Jun; 189(6):2186-93. PubMed ID: 23246476
[TBL] [Abstract][Full Text] [Related]
14. Validation of overactive bladder questionnaire (1-week recall version) in medically complex elderly patients with overactive bladder.
Barsdorf AI; Carlsson M; Bushmakin AG; Quinn S; Cappelleri JC; Pleil A
Int Urogynecol J; 2017 Dec; 28(12):1857-1863. PubMed ID: 28378111
[TBL] [Abstract][Full Text] [Related]
15. Reliability and validity of the Overactive Bladder Symptom Score in Spanish (OABSS-S).
Weinberg AC; Brandeis GH; Bruyere J; Tsui JF; Weiss JP; Rutman MP; Blaivas JG
Neurourol Urodyn; 2012 Jun; 31(5):664-8. PubMed ID: 22488591
[TBL] [Abstract][Full Text] [Related]
16. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.
Garely AD; Lucente V; Vapnek J; Smith N
Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526
[TBL] [Abstract][Full Text] [Related]
17. Test - retest reliability of the Indonesian version of the Overactive Bladder Symptom Score (OABSS) and its correlation with standard assessment tools.
Sumardi R; Mochtar CA; Junizaf ; Santoso BI; Tjahjodjati ; Purwara BH; Hardjowijoto S; Paraton H; Yunaidi DA
Acta Med Indones; 2012 Jul; 44(3):214-21. PubMed ID: 22983076
[TBL] [Abstract][Full Text] [Related]
18. Impact of onabotulinumtoxinA on quality of life and practical aspects of daily living: A pooled analysis of two randomized controlled trials.
Everaert K; Gruenenfelder J; Schulte-Baukloh H; Egerdie RB; Khalaf K; Joshi M; Ni Q; Sussman D
Int J Urol; 2015 Dec; 22(12):1131-7. PubMed ID: 26391359
[TBL] [Abstract][Full Text] [Related]
19. The psychometric validation of the OAB family impact measure (OAB-FIM).
Coyne KS; Matza LS; Brewster-Jordan J; Thompson C; Bavendam T
Neurourol Urodyn; 2010 Mar; 29(3):359-69. PubMed ID: 19274760
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in patients with overactive bladder: validation and psychometric properties of the Spanish Overactive Bladder Questionnaire-short Form.
Arlandis S; Ruiz MA; Errando C; Villacampa F; Arumí D; Lizarraga I; Rejas J
Clin Drug Investig; 2012 Aug; 32(8):523-32. PubMed ID: 22741748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
